Company Information
- CEO
- Dr. Kuno Sommer
- Investor Relations
- Patrik Richard
Berna Biotech AG is a biotechnology company specialised in the development and production of immunobiological preparations, mainly viral and bacterial vaccines. The firm was founded in 1898 under the name of Schweiz. Serum- und Impfinstitut Bern.
Trading Information
- Sector
- Health Care - 4500
- Regulatory Standard
- Swiss Reporting Standard
- Security Number
- 1246277
- ISIN
- CH0012462773
- Symbol
- BBIN
- Index member
- SPI
Intermediaries
- Listing Agent
- Lombard Odier & Cie
- Lead Bank
- Lombard Odier & Cie.
- Auditor
- KPMG Fides Peat
Information on the Issue
| Security Details | |
|---|---|
| First Listing | 26.06.2001 |
| Class of Share | Action nominative |
| Nominal Value | 10.00 CHF |
| Total Shares outstanding (post issue; incl. Greenshore - if any) | 1000000 |
| Allocation Details | |
|---|---|
| Primary Shares | n/a |
| Secondary Shares | n/a |
| Primary Greenshoe | n/a |
| Secondary Greenshoe | n/a |
| Greenshoe Details | |
|---|---|
| Executed | no GS at all |
| Ex-date | n/a |
| Executed number of shares | n/a |
| First Trading Day Details | |
|---|---|
| First Trading | 26.06.2001 |
| Price Range | n/a |
| Issue Price | 912.00 CHF |
| First Open | 939.00 CHF |
| First Close | 880.00 CHF |
| Transaction size in Mio. (incl. executed Greenshoe) | 0 CHF |
| Market Capitalisation in Mio. (based on first closing price) | 880 CHF |
Financial Statement
| Number of Employees | 698 2000 |
| Net Revenues in Mio. | 151.7 CHF 2000 |
| Net Gain in Mio. | n/a |